Pharmafile Logo
Pharmafocus logo
Advanced Search

Specialist medical education company, Wave, has made six new appointments to reflect the growth in their business over the last 3 months.

December 13, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Becky Robbins, a former Healthcare Analyst at GlobalData, and Lorna Bosdet, formerly Account Executive at Sciterion have joined as Senior …

News
Press release
ceo_david_hallal_image_sqaure_image

Alexion loses CEO & CFO as internal investigation continues

December 13, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alexion

Alexion Pharmaceuticals has revealed that its CEO David Hallal (pictured) and CFO Vikas Sinha have resigned effective immediately in connection …

Appointment
medicity

Medicity in £1.4 million expansion in boost for life sciences

December 13, 2016
Manufacturing and Production BioCity, Boots, medicity

Medicity has announced that it has managed to raise the funds to refurbish an additional 29,800 square feet of space, …

News
13bg_fire_at_biocon

Major fire ravages Biocon subsidiary complex in India

December 13, 2016
Manufacturing and Production Biocon, Syngene

A subsidiary of Indian biopharmaceutical firm Biocon was gutted by a major fire at Electronic City, Bangalore on 12 December, …

News
sun_pharma

Sun Pharma’s Halol plant’s leaky roof irks FDA

December 13, 2016
Manufacturing and Production FDA, Sun Pharma, inspection

The FDA’s two week inspection of Sun Pharmaceutical’s Halol plant produced a 14-page report, with some criticisms reserved for poorly …

News
alexion_sign

Alexion loses CEO & CFO as internal investigation continues

December 12, 2016
Business Services, Manufacturing and Production, Medical Communications

Alexion Pharmaceuticals has revealed that its CEO David Hallal and CFO Vikas Sinha have resigned effective immediately in connection with …

News
jevtana_0

Scottish Medicines Consortium approves Sanofi’s prostate cancer drug

December 12, 2016
Manufacturing and Production, Sales and Marketing Jevtana, Sanofi, prostate cancer

Sanofi’s speciality care global business unit Sanofi Genzyme has announced that the Scottish Medicines Consortium has accepted the company’s Jevtana …

News
emma-harvey0006_horizontal

Rare challenges: Meeting patient needs and delivering medical innovation in ultra-rare diseases

December 12, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alexion, ultra rare disease, ultra-rare disease

Dr Emma Harvey, ‎senior medical director at Alexion Pharmaceuticals UK, shares her views on the challenges of working in the …

Feature

Personalised leukaemia vaccine shows promise in new trial

December 12, 2016
Sales and Marketing leukaemia

A personalised cancer vaccine has proven to have significant efficacy in the treatment of acute myeloid leukaemia (AML), researchers at …

News
basel_site

Phase 3 eye drug combo failure for Novartis

December 12, 2016
Research and Development, Sales and Marketing Novartis, ophthotech

Novartis’ has failed in its attempt to expand the applications of its anti-VEGF eye treatment Lucentis (ranibizumab) after the drug …

News
shutterstock_311949818

Neurodegenerative market to be worth $45 billion by 2022

December 12, 2016
Sales and Marketing Biogen, GBI Research, Novartis, Roche, Sanofi, neurodegenerative

Neurodegenerative disorders including Alzheimer’s, Parkinson’s, Huntington’s, amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) form a lucrative worldwide market which …

News

First generic copy of Roche’s Tamiflu hits US market

December 12, 2016
Sales and Marketing Alvogen, Roche, Tamiflu

Drugmaker Alvogen has released the first generic version of Roche’s flu medication Tamiflu (oseltamivir) in the US, where it expects …

News
shutterstock_38078521

AZ and Lilly come together to battle Alzheimer’s

December 9, 2016
Research and Development, Sales and Marketing AZ, lilly

Pharma titans Eli Lilly and AstraZeneca have announced they are to join forces to co-develop a potential Alzheimer’s treatment, currently …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

December 9, 2016
Medical Communications top ten

Christmas is drawing ever closer, but that doesn’t mean the industry is slowing down. This week, features from the latest …

News
astrazeneca_plaque

AZ to terminate 700 US jobs

December 9, 2016
Manufacturing and Production, Medical Communications AstraZeneca, job cuts

AstraZeneca has revealed that it plans to cut 700 positions across the US by 10 February 2017, including 120 positions …

News
china_pic

Top Pharmaceutical Markets 2016: China

December 9, 2016
Business Services, Manufacturing and Production, Medical Communications, Sales and Marketing China, market analysis

Originally featured in Pharmafile Autumn 2016, a report from the United States International Trade Administration sheds light on the Chinese …

News
mice

Flickering LEDs could light the way for new Alzheimer’s treatment

December 8, 2016
Medical Communications, Research and Development Alzheimer's, Cognito therapeutics, mice

Research to find a potential new treatment for Alzheimer’s was hit a blow late last month, as Eli Lilly discontinued …

News
abbvie_0

European thumbs up for Abbvie leukaemia drug

December 8, 2016
Medical Communications, Sales and Marketing AbbVie, Venclyxto

Abbvie has confirmed its Venclyxto (venetoclax) has been granted marketing authorisation by the European Commission (EC) as a monotherapy for …

News
novartis_window

Novartis’ drug doubly effective as chemotherapy for treating lung cancer

December 8, 2016
NSCLC, Novartis, chemotherapy

Novartis have released that its drug, Zykadia, in Phase III trials, was twice as effective at slowing progression in advanced …

News
sicorbio

Teva embroiled in internal bribery investigation

December 8, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva, bribery

Israeli pharmaceutical firm Teva has confirmed it is embroiled in an ongoing internal investigation into allegations of bribery, after the …

News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026